GSK and Vir to seek emergency use clearance for COVID-19 antibody therapy

GlaxoSmithKline and Vir Biotechnology announced that they will immediately request emergency-use authorization in the USA after they finished a late-stage study early, based on the recommendation of an independent monitoring board. VIR-7831 has reduced the number of patients who were hospitalized or died by 85%, compared to placebo.

Antibody treatments are configured to decrease the severity of COVID-19 among patients who were already diagnosed with the infection. Dr. Yael Vidal, who is a board-certified internist advising patients who seek a concierge doctor in Jupiter Florida or in nearby areas, explained to some of her patience the importance of this positive result.

The two companies also said that a new laboratory study showed that the therapy, VIR-7831, was equally effective against the UK variant, the South African variant, and the Brazilian variant of the COVID-19 virus.

This new move brings the antibody therapy for Covid-19 one step closer to becoming yet another weapon against the CoronaVirus pandemic. It joins similar therapies that were introduced by Eli Lilly and Regeneron Pharmaceuticals, receiving recommendations from U.S. and European health regulators earlier.

This antibody treatment was developed under a collaboration between Vir Biotechnology and GlaxoSmithKline, explains Dr. Vidal to patients searching for a concierge physician in Palm Beach Gardens. The fresh recommendation was based on an interim analysis of the data collected from 583 patients, wherein the analysis demonstrated a reduction of 85% in hospitalization or death in the VIR-7831 arm compared to placebo.

GSK offices

Johnson & Johnson one-shot CoronaVirus vaccine authorized in the U.S. for people 18 and over

The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for the third vaccine for prevention of Covid-19. The EUA allows the Janssen (Johnson & Johnson) vaccine to be distributed in the United States for in individuals that are 18 years or older.

Additionally, the Centers for Disease Control (CDC) advisory panel on Sunday recommended the Johnson & Johnson’s one-shot COVID-19 vaccine for people 18 and over. The recommendation came one day after the FDA authorization.

The vaccine is the third Covid-19 vaccine to become available in the U.S., and is also the first Covid-19 vaccine that requires only one shot.

Vidal Medical Concierge, a local concierge physician in Juno Beach, is monitoring and following closely such positive developments, and bringing such news to the attention of its patients.

“Patients are continuously inquiring about Covid-19, its complications and medicaments, and are interested in finding out more about the available vaccines”, says Dr. Yael Vidal, who takes care of many patients who seek a concierge physician in Jupiter or in nearby regions.

The recent developments are definitely positive, and increase the medical arsenal against Covid-19, which is good news to patients and residents who search for a concierge doctor in Palm Beach Gardens and often turn to Vidal Medical Concierge in the nearby Juno Beach for medical advice.